
        Emanuel Grunberg, a bacteriologist who developed drugs against infectious diseases, died on Jan. 16 at his home in Delray Beach, Fla. A former resident of North Caldwell, N.J., he was 72.
        The cause was cardiac arrest, according to the Dancy Funeral Home in Caldwell.
        Dr. Grunberg had a 40-year career at Hoffman-La Roche, the pharmaceutical company in New Jersey, becoming director of chemotherapy and diagnostic research at the company's Pharmaceutical Laboratories in Nutley. He retired in 1986.
        He developed anti-tuberculosis drugs like Rimifon and Marsilid. He began at Hoffman-La Roche in 1946 and formed a team with Dr. Albert J. Schnitzer to make those drugs safe for tests on TB victims.
        Born in Everett, Mass., he graduated from the University of Alabama and earned a Ph.D. in medical sciences at Yale University in 1946.
        He is survived by his wife of 49 years, Eleanor Hoffman Grunberg; two sons, Dr. Steven M. of Burlington, Vt., and Dr. Neil E. of Bethesda, Md., and seven grandchildren.
      